Redox Status Response of Physical Exercise Training in Women with Breast Cancer during Trastuzumab Therapy

Trastuzumab is indicated in the adjuvant setting for the early and intermediate stages of breast cancer (BC) positive for epidermal growth factor receptor 2 (HER2). Although HER2 in BC patients tends to disrupt pro-oxidant and inflammatory signaling, the influence of trastuzumab in modulating this p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hojan, Katarzyna, Gerreth, Karolina, Procyk, Danuta, Mania, Krystian, Zalewska, Anna, Maciejczyk, Mateusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602187/
https://www.ncbi.nlm.nih.gov/pubmed/36292486
http://dx.doi.org/10.3390/healthcare10102039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602187/
https://www.ncbi.nlm.nih.gov/pubmed/36292486
http://dx.doi.org/10.3390/healthcare10102039

Ejemplares similares